Dynamic atlas-based segmentation and quantification of neuromelanin-rich brainstem structures in Parkinson disease

We present a dynamic atlas composed of neuromelanin-enhanced magnetic resonance brain images of 40 healthy subjects. The performance of this atlas is evaluated on the fully automated segmentation of two paired neuromelanin-rich brainstem healthy structures: the substantia nigra pars compacta and the...

Descripción completa

Detalles Bibliográficos
Autores: Ariz Galilea, Mikel, Abad, Ricardo C., Castellanos, Gabriel, Martínez, Martín, Muñoz Barrutia, Arrate, Fernández Seara, María A., Pastor, Pau, Pastor, María A., Ortiz de Solórzano, Carlos
Tipo de recurso: artículo
Estado:Versión aceptada para publicación
Fecha de publicación:2019
País:España
Institución:Universidad Pública de Navarra
Repositorio:Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
OAI Identifier:oai:academica-e.unavarra.es:2454/56450
Acceso en línea:https://hdl.handle.net/2454/56450
Access Level:acceso abierto
Palabra clave:Parkinson disease
Neuromelanin
Magnetic resonance imaging
Multi-image atlas based segmentation
Neural Network based classifier.
Descripción
Sumario:We present a dynamic atlas composed of neuromelanin-enhanced magnetic resonance brain images of 40 healthy subjects. The performance of this atlas is evaluated on the fully automated segmentation of two paired neuromelanin-rich brainstem healthy structures: the substantia nigra pars compacta and the locus coeruleus. We show that our dynamic atlas requires in average 60% less images and, therefore, 60% less computation time than a static multi-image atlas while achieving a similar segmentation performance. Then, we show that by applying our dynamic atlas, composed of healthy subjects, to the segmentation and neuromelanin quantification of a set of brain images of 39 Parkinson disease patients, we are able to find significant quantitative differences in the level of neuromelanin between healthy subjects and Parkinson disease patients, thus opening the door to the use of these structures as image biomarkers in future computer aided diagnosis systems for the diagnosis of Parkinson disease.